IP Library Assignment 067141/0230
Patent Assignment
Reel/Frame 067141/0230

Assignment of Assignor's Interest

Recorded: 2024-04-17 Pages: 6
Assignors
RÖTHELI, ANDREAS RENÉ
Executed: 2023-08-30
BORTHS, CHRISTOPHER J.
Executed: 2023-08-24
Assignee
AMGEN, INC.
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CALIFORNIA, 91320-1799
Covered Property (1)
Salts of Obicetrapib and Processes for their Manufacture and Intermediates Thereof
Application: 18/637,425 →
Publication: US 2024/0391897
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 17, 2024
From: CUI, SHENG
To: NEWAMSTERDAM PHARMA B.V.
Reel/Frame 067141/0122 →
Assignment of Assignor's Interest Apr 17, 2024
From: SMOLENSKAYA, VALERIYA NIKOLAYEVNA
To: TRICLINIC LABS, INC.
Reel/Frame 067141/0236 →
Assignment of Assignor's Interest Apr 19, 2024
From: AMGEN INC.
To: NEWAMSTERDAM PHARMA B.V.
Reel/Frame 067170/0085 →
Assignment of Assignor's Interest Apr 19, 2024
From: TRICLINIC LABS, INC.
To: NEWAMSTERDAM PHARMA B.V.
Reel/Frame 067170/0090 →
Assignment of Assignor's Interest May 1, 2024
From: KISHIDA, MUNEKI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 067287/0445 →
Assignment of Assignor's Interest Dec 6, 2024
From: MITSUBISHI TANABE PHARMA CORPORATION
To: NEWAMSTERDAM PHARMA B.V.
Reel/Frame 069510/0351 →